You are here

  • Home
  • Archive
  • Volume 29, Issue 3
  • Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available

Citation Tools

Article menu
Download PDFPDF
PostScript
Letter
Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Messori A, Bartoli L, Mengato D, et al
Chimeric antigen receptor T-cell (CART) therapy in non-Hodgkin’s lymphoma: the survival gain improves as more mature follow-up data become available
European Journal of Hospital Pharmacy 2022;29:e1.